Palatin Technologies Inc. (PTN) Fundamentals

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
SHARE INFORMATION
Market Cap$ 59,273,269
Shares Outstanding9,290,481
Float9,100,847
Percent Float97.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ -188,597
Latest Fiscal EPS$ -3.50
Latest Fiscal Date2021-06-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions105
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months2,090,160
Institutional Holdings Percent9.9%
Institutional Sold Previous 3 Months643,418
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,558,187
Insider Holdings Percent11.2
Insider Sold Previous 3 Months-
Insider Shares Owned25,934,172
TRADING INFO
52 Week High$ 24.00
52 Week Low$ 4.00
52 Week High Change$ -44.81
21 Day Moving Average$ 6.2455
21 Day Extended Moving Average$ 6.7596
50 Day Moving Average$ 6.6125
50 Day Extended Moving Average$ 6.7684
200 Day Moving Average$ 9.2193
200 Day Extended Moving Average$ 8.7518
10 Day Average Volume175,623
20 Day Average Volume208,383
30 Day Average Volume160,785
50 Day Average Volume107,477
Alpha-0.005753
Beta1.1191
Standard Deviation0.200689
R20.079168
7 Day Price Change$ -1.58
7 Day Percent Change-19.85%
21 Day Price Change$ 1.78
21 Day Percent Change38.7%
30 Day Price Change$ 0.5275
30 Day Percent Change9.01%
Month to Date Price Change$ 1.36
Month to Date Percent Change27.09%
Quarter to Date Price Change$ -0.635
Quarter to Date Percent Change-9.05%
180 Day Price Change$ -3.95
180 Day Percent Change-38.24%
200 Day Price Change$ -3.37
200 Day Percent Change-34.58%
Year to Date Price Change$ -6.41
Year to Date Percent Change-50.12%

Palatin Technologies Inc. (PTN) Key Ratios

PROFITABILITY
EBIT Margin-4,277.6%
EBITDA Margin-4,266.5%
Pre-Tax Profit Margin-5,378.6%
Profit Margin Count0.0%
Gross Margin-559.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 697,719
Revenue Per Share$ 0.0751
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.10
Total Debt To Equity0.10
Int Coverage-1,464.10
Current Ratio3.50
Leverage Ratio1.50
Quick Ratio3.20
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-1.60
Enterprise Value$ 30,488,004
Price to Sales84.9529
Price to Free Cash-2.60
PE High Last 5 Years15.30
Price To Book3.60
Price To Cash Flow2.50
PE Low Last 5 Years-4.80
Price to Tangible Book2.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.60
Invoice Turnover0.20
Assets Turnover0.00
Return Assets-62.18
Return on Equity-85.45
Return on Capital-79.82

Palatin Technologies Inc. (PTN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOCarl Spana
Emplyoees26
Last AuditUQ
CIK0000911216
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4B Cedar Brook Drive
Cranbury, NJ 8512
Websitehttps://www.palatin.com
Facsimile+1 609 495-2202
Telephone+1 609 495-2200
Emailinvestors@palatin.com


Your Recent History
AMEX
PTN
Palatin Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.